如何改善心动过速性心肌病患者的临床结局。对卡茨等人的评论。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412。
How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412.
作者信息
Kataoka Naoya, Imamura Teruhiko
机构信息
Second Department of Internal Medicine, University of Toyama, Toyama 930-0194, Japan.
出版信息
J Clin Med. 2023 Aug 1;12(15):5065. doi: 10.3390/jcm12155065.
Abstract
The clinical course of tachycardia-induced cardiomyopathy (TICM) has not yet been well studied thus far [...].
摘要
迄今为止，心动过速性心肌病（TICM）的临床病程尚未得到充分研究[……]。
相似文献
1
How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412.如何改善心动过速性心肌病患者的临床结局。对卡茨等人的评论。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412。
J Clin Med. 2023 Aug 1;12(15):5065. doi: 10.3390/jcm12155065.
2
Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412".对片冈直和、今村彻的回复。如何改善心动过速性心肌病患者的临床结局。对“卡茨等人。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412”的评论
J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.
3
Radiofrequency catheter ablation of atrioventricular accessory pathways in 3 dogs with subsequent resolution of tachycardia-induced cardiomyopathy.对3只犬的房室旁道进行射频导管消融，随后心动过速性心肌病得到缓解。
J Vet Intern Med. 1999 Jul-Aug;13(4):361-71. doi: 10.1892/0891-6640(1999)013<0361:rcaoaa>2.3.co;2.
4
Fetal dilated cardiomyopathy caused by persistent junctional reciprocating tachycardia.持续性交接区折返性心动过速致胎儿扩张型心肌病。
Ultrasound Obstet Gynecol. 2009 May;33(5):595-8. doi: 10.1002/uog.6364.
5
Association of preprocedural cardiac magnetic resonance imaging with outcomes of ventricular tachycardia ablation in patients with idiopathic dilated cardiomyopathy.术前心脏磁共振成像与特发性扩张型心肌病患者室性心动过速消融治疗结局的相关性。
Heart Rhythm. 2017 Oct;14(10):1487-1493. doi: 10.1016/j.hrthm.2017.06.003. Epub 2017 Jun 9.
6
7
[Clinical characteristics and follow-up study of tachycardia-induced cardiomyopathy in 12 children].12例儿童心动过速性心肌病的临床特征及随访研究
Zhonghua Er Ke Za Zhi. 2011 Dec;49(12):933-8.
8
Frequency and predictors of tachycardia-induced cardiomyopathy in patients with persistent atrial flutter.持续性心房扑动患者心动过速性心肌病的发生率及预测因素
Can J Cardiol. 2009 Aug;25(8):469-72. doi: 10.1016/s0828-282x(09)70119-9.
9
Delayed diagnosis of dilated thyrotoxic cardiomyopathy with coexistent multifocal atrial tachycardia: a case report.伴有多灶性房性心动过速的扩张型甲状腺毒性心肌病的延迟诊断：病例报告。
BMC Cardiovasc Disord. 2021 Mar 4;21(1):124. doi: 10.1186/s12872-021-01935-5.
10
Outcomes in catheter ablation of ventricular tachycardia in dilated nonischemic cardiomyopathy compared with ischemic cardiomyopathy: results from the Prospective Heart Centre of Leipzig VT (HELP-VT) Study.与缺血性心肌病相比，扩张型非缺血性心肌病患者心室内速导管消融的结果：来自莱比锡 VT 前瞻性心脏中心（HELP-VT）研究的结果。
Circulation. 2014 Feb 18;129(7):728-36. doi: 10.1161/CIRCULATIONAHA.113.003063. Epub 2013 Nov 8.
引用本文的文献
1
Reply to Kataoka, N.; Imamura, T. How to Improve Clinical Outcomes in Patients with Tachycardia-Induced Cardiomyopathy. Comment on "Katz et al. Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy. 2023, , 1412".对片冈直和、今村彻的回复。如何改善心动过速性心肌病患者的临床结局。对“卡茨等人。与特发性扩张型心肌病相比，心动过速性心肌病的长期结局。2023年，，1412”的评论
J Clin Med. 2023 Sep 8;12(18):5849. doi: 10.3390/jcm12185849.
本文引用的文献
1
Long-Term Outcomes of Tachycardia-Induced Cardiomyopathy Compared with Idiopathic Dilated Cardiomyopathy.与特发性扩张型心肌病相比，心动过速性心肌病的长期预后
J Clin Med. 2023 Feb 10;12(4):1412. doi: 10.3390/jcm12041412.
2
Catheter ablation improves cardiovascular outcomes in patients with atrial fibrillation and heart failure: a meta-analysis of randomized controlled trials.导管消融术改善心房颤动合并心力衰竭患者的心血管结局：一项随机对照试验的荟萃分析。
Europace. 2023 Feb 16;25(2):341-350. doi: 10.1093/europace/euac173.
3
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2022年美国心脏协会/美国心脏病学会/美国心力衰竭学会心力衰竭管理指南：美国心脏病学会/美国心脏协会临床实践指南联合委员会报告
J Am Coll Cardiol. 2022 May 3;79(17):e263-e421. doi: 10.1016/j.jacc.2021.12.012. Epub 2022 Apr 1.
4
Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure.房颤伴心力衰竭患者导管消融术后的剧烈心脏逆向重构。
Medicina (Kaunas). 2021 May 20;57(5):511. doi: 10.3390/medicina57050511.
5
Arrhythmia-Induced Cardiomyopathy: JACC State-of-the-Art Review.心律失常性心肌病：美国心脏病学会最新综述
J Am Coll Cardiol. 2019 May 14;73(18):2328-2344. doi: 10.1016/j.jacc.2019.02.045.
6
Catheter Ablation for Atrial Fibrillation with Heart Failure.心力衰竭合并心房颤动的导管消融治疗。
N Engl J Med. 2018 Feb 1;378(5):417-427. doi: 10.1056/NEJMoa1707855.
7
Rhythm control versus rate control for atrial fibrillation and heart failure.心房颤动与心力衰竭的节律控制与率控制
N Engl J Med. 2008 Jun 19;358(25):2667-77. doi: 10.1056/NEJMoa0708789.
Zotero 插件